CD8A and neoplasm: For example, it is unknown whether intrinsic differences in the T cell receptor (TCR) repertoire of individuals can influence the outcome of ICI therapy by affecting the frequency and/or variety of CD8 tumor-infiltrating lymphocytes (TILs) in responders versus (vs.)non-responders.